2,830
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Epstein–Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppression

, , , , &
Article: 1683346 | Received 12 Aug 2019, Accepted 16 Oct 2019, Published online: 03 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zhi-He Liu, Lin Zhang, Fan-Jing Jing, Shu-Xin Xiao, Yan Gao, Hai-Yan Bian & Xia Zhao. (2021) Genetic Polymorphisms in NLRP3 Inflammasome-Associated Genes in Patients with B-Cell Non-Hodgkin’s Lymphoma. Journal of Inflammation Research 14, pages 5687-5697.
Read now

Articles from other publishers (12)

Ji-Wei Li, Chao Deng, Xiao-Yan Zhou & Renfang Deng. (2024) The biology and treatment of Epstein-Barr virus-positive diffuse large B cell lymphoma, NOS. Heliyon 10:1, pages e23921.
Crossref
D. G. Sausen, M. C. Poirier, L. M. Spiers & E. N. Smith. (2023) Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival. Frontiers in Immunology 14.
Crossref
Kun Qian, Shengli Fu, Junru Wang, Yuan Li, Jianan Xian & Jianmin Ye. (2023) Major histocompatibility complex class IIα and II β of pufferfish ( Takifugu obscurus ): Identification and functional characterization in response to bacterial challenge . Journal of Fish Diseases 46:10, pages 1049-1064.
Crossref
Wesley I. Soo Hoo, Kaylie Higa & Alison A. McCormick. (2023) Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma. Biology 12:7, pages 983.
Crossref
Taishi Takahara, Shigeo Nakamura, Toyonori Tsuzuki & Akira Satou. (2023) The Immunology of DLBCL. Cancers 15:3, pages 835.
Crossref
Wei Xie, L. Jeffrey Medeiros, Shaoying Li, Guilin Tang, Guang Fan & Jie Xu. (2022) PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas. Biomedicines 10:7, pages 1587.
Crossref
Erik Hellbacher, Christer Sundström, Daniel Molin, Eva Baecklund & Peter Hollander. (2022) Expression of PD-1, PD-L1 and PD-L2 in Lymphomas in Patients with Pre-Existing Rheumatic Diseases—A Possible Association with High Rheumatoid Arthritis Disease Activity. Cancers 14:6, pages 1509.
Crossref
Xiaoxu Li & Wenling Zhang. (2021) Expression of PD-L1 in EBV-associated malignancies. International Immunopharmacology 95, pages 107553.
Crossref
Bingnan Liu, Yuanyuan Shao & Rong Fu. (2021) Current research status of HLA in immune‐related diseases. Immunity, Inflammation and Disease 9:2, pages 340-350.
Crossref
Taishi Takahara, Akira Satou, Eri Ishikawa, Kei Kohno, Seiichi Kato, Yuka Suzuki, Emiko Takahashi, Akiko Ohashi, Naoko Asano, Toyonori Tsuzuki & Shigeo Nakamura. (2020) Clinicopathological analysis of neoplastic PD-L1-positive EBV+ diffuse large B cell lymphoma, not otherwise specified, in a Japanese cohort. Virchows Archiv 478:3, pages 541-552.
Crossref
园园 郝. (2021) Research Progress of Epstein Barr Virus Associated Lymphoma. World Journal of Cancer Research 11:02, pages 38-47.
Crossref
Basit Salik, Mark J. Smyth & Kyohei Nakamura. (2020) Targeting immune checkpoints in hematological malignancies. Journal of Hematology & Oncology 13:1.
Crossref